SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-070378
Filing Date
2022-11-09
Accepted
2022-11-09 09:05:37
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168230-8k_virpax.htm   iXBRL 8-K 25582
2 PRESS RELEASE OF VIRPAX PHARMACEUTICALS, INC. ISSUED NOVEMBER 9, 2022 ea168230ex99-1_virpax.htm EX-99.1 78952
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2465
  Complete submission text file 0001213900-22-070378.txt   296317

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vrpx-20221109.xsd EX-101.SCH 3239
5 XBRL LABEL FILE vrpx-20221109_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vrpx-20221109_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168230-8k_virpax_htm.xml XML 3722
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 221370884
SIC: 2834 Pharmaceutical Preparations